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Abstract  
Methamphetamine (METH) is a highly addictive psychostimulant drug of abuse that 
negatively interferes with neurogenesis. In fact, we have previously shown that METH 
triggers stem/progenitor cell death and decreases neuronal differentiation in the dentate 
gyrus (DG). Still, little is known regarding its effect on DG stem cell properties. Herein, 
we investigate the impact of METH on mice DG stem/progenitor cell self-renewal 
functions. METH (10 nM) decreased DG stem cell self-renewal, while 1 nM delayed 
cell cycle in the G0/G1-to-S phase transition and increased the number of quiescent 
cells (G0 phase), which correlated with a decrease in cyclin E, pEGFR and pERK1/2 
protein levels. Importantly, both drug concentrations (1 or 10 nM) did not induce cell 
death. In accordance with the impairment of self-renewal capacity, METH (10 nM) 
decreased Sox2
+
/Sox2
+
 while increased Sox2
-
/Sox2
-
 pairs of daughter cells. This effect 
relied on N-methyl-D-aspartate (NMDA) signaling, which was prevented by the NMDA 
receptor antagonist, MK-801 (10 µM). Moreover, METH (10 nM) increased 
doublecortin (DCX) protein levels consistent with neuronal differentiation. In 
conclusion, METH alters DG stem cell properties by delaying cell cycle and decreasing 
self-renewal capacities, mechanisms that may contribute to DG neurogenesis 
impairment followed by cognitive deficits verified in METH consumers.  
 
Keywords: methamphetamine, neurogenesis, dentate gyrus, stem/progenitor cells, cell 
cycle, cell fate division  
 
Abbreviations: bFGF2, basic Fibroblast growth factor 2; BrdU, 5-Bromo-2’-
deoxyuridine; Cdk, Cyclin-dependent kinase; DCX, doublecortin; DG, Dentate gyrus; 
EGF, Epidermal growth factor; EGFR, Epidermal growth factor receptor; ERK, 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
3 
 
Extracellular-signal-regulated kinases 1/2; GAPDH, Glyceraldehyde 3-phosphate 
dehydrogenase; GFAP, Glial fibrillary acidic protein; MAPK, Mitogen-activated 
protein kinase; MDMA, 3,4-Methylenedioxymethamphetamine; MEK1, MAPK/ERK 
kinase 1; METH, Methamphetamine; MK-801, (5R,10S)-(–)-5-Methyl-10,11-dihydro-
5H-dibenzo[a,d]cylcohepten-5,10-imine maleate; NMDA, N-methyl-D-aspartate; 
pEGFR, phospho-epidermal growth factor receptor; pERK1/2, phospho-extracellular-
signal-regulated kinases 1/2; SGZ, Subgranular zone; Sox2, SRY (sex determining 
region Y)-box 2; SVZ, Subventricular zone; TUNEL, Terminal deoxynucleotidyl 
transferase dUTP nick-end labeling.  
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1 Introduction 
Methamphetamine (METH) is a highly addictive drug whose consumption has been 
increasing worldwide and turned to be a public health problem (Silva et al., 2010). 
Several studies have extensively described the negative effects of METH in the Central 
Nervous System (Gonçalves et al., 2014; Krasnova and Cadet, 2009), concluding that 
METH abusers exhibit smaller hippocampal volume, which was positively correlated 
with poorer memory performance (Thompson et al., 2004). Accordingly, animal studies 
have clearly demonstrated hippocampal neuronal dysfunction (Gonçalves et al., 2010), 
as well as cognitive deficits induced by this psychostimulant (Simões et al., 2007). 
Nevertheless, the mechanisms of METH-induced memory deficits are still poorly 
understood, but pieces of evidence show that neurogenesis is tightly related to memory. 
In fact, reduction in the number of immature neurons induces deficits in long-term 
retention of spatial cognitive functions (Deng et al., 2009), and ablation of hippocampal 
neurogenesis impairs memory performance related to pattern separation functions 
(Clelland et al., 2009).  
The information available regarding the effect of METH on neurogenesis 
describes that, in the dentate gyrus (DG), cell proliferation is decreased in gerbils 
(postnatal day 30) administered once with the drug at postnatal day 14-20 (50 mg/kg) 
(Hildebrandt et al., 1999). On the other hand, a lower dose of METH (25 mg/kg) 
transiently decreased cell proliferation in the same region (Teuchert-Noodt et al., 2000). 
Furthermore, a chronic METH administration (1 mg/kg/day for 14 days) had no effect 
on the number of proliferating cells in mice DG (Maeda et al., 2007). Interestingly, 
Wistar rats self-administered with METH (0.05 mg/kg/infusion, 1 h intermittent access, 
2x a week during 28 days) displayed an increase in DG cell proliferation as well as in 
neuronal differentiation, whereas both short (1 h/day) and long (6 h/day) access 
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decreased proliferation and differentiation followed by a reduced number of DG granule 
cell neurons (Mandyam et al., 2008). Furthermore, self-administration of METH (1 
h/day access METH for 13 days) increased the number of radial glia-like cells (type 1 
cells), but decreased the proportion of preneuronal neuroblasts (type 2a cells) (Yuan et 
al., 2011) showing that at different maturation stages cells respond differently to an 
external stimuli (Tashiro et al., 2007). Also, daily access to METH (6 h/day for 4 or 13 
days) decreased the number of proliferating cells in the DG without changing, however, 
the length of S-phase of the cell cycle (Yuan et al., 2011). In vitro studies also point that 
METH reduced proliferation of rat hippocampal neural progenitor cells (Tian et al., 
2009; Venkatesan et al., 2011). Additionally, our group recently verified that a nontoxic 
concentration of METH (1 nM for 7 days) decreased the number of mature neurons in 
DG-derived neurosphere cultures (Baptista et al., 2012). Concerning the subventricular 
zone (SVZ), we have also shown that METH decreases cell proliferation, neuronal 
differentiation and maturation of stem/progenitor cells (Bento et al., 2011).  
Overall, it seems clear that METH interferes with hippocampal neurogenesis, 
but many questions remain unanswered. In fact, the direct effect of this drug on stem 
cell self-renewal capacities has never been addressed before. Herein, we show that 
METH delays cell cycle progression from G0/G1-to-S phase. This effect could be due 
to the down-regulation of cyclin E, a cyclin involved in the progression through the G1 
phase and initiation of DNA replication in the S phase, and to the decrease of epidermal 
growth factor receptor (EGFR) and extracellular-signal-regulated kinases 1/2 (ERK1/2) 
phosphorylation, mediators in the MAPK signaling pathway involved in cell 
proliferation progression. Also, METH decreases DG stem cell self-renewal capacities, 
which seems to involve NMDA receptors. In conclusion, the present work reveals a 
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negative impact of METH on DG stem cell capacities that can contribute to memory 
deficits upon METH consumption. 
 
2 Material and methods 
 
2.1 Dentate gyrus neurosphere cultures 
Post-natal 1-3-day-old C57BL/6J mice were sacrificed by decapitation and brains were 
placed in sterile saline solution. Afterwards, meninges were removed and DG fragments 
were dissected from 450 µm-thick brain coronal sections, digested in 0.025% trypsin 
and 0.265 mM EDTA (both from Life Technologies, Carlsbad, CA, USA), and single 
cells were obtained by gentle trituration. Then, cells were diluted in serum-free culture 
medium (SFM) composed of Dulbecco’s modified Eagle’s medium/Ham’s (DMEM) F-
12 medium GlutaMAX-I supplemented with 100 U/ml penicillin, 100 µg/ml 
streptomycin, 1% B27 supplement, 5 ng/ml epidermal growth factor (EGF) and 2.5 
ng/ml basic fibroblast growth factor (bFGF-2) (all from Life Technologies). Afterwards, 
cells were plated in uncoated Petri dishes and neurospheres were allowed to develop for 
6 days in a 95% air-5% CO2 humidified atmosphere at 37ºC. At 6 days, the 
neurospheres mean diameter was 90.22 ± 2.24 μm (measurements performed on 2 
independent cultures).  
Experimental procedures were performed according to the guidelines of the 
European Communities Council Directives (2010/63/EU) and the Portuguese law for 
the care and use of experimental animals (DL nº129/92). All efforts were made to 
minimise animal suffering and to reduce the number of animals. 
 
2.2 Cell death assay 
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DG neurospheres were exposed to 10 or 100 nM METH (Department of Chemistry and 
Biochemistry, Faculty of Sciences, University of Porto, Portugal) for 24 h (Fig. 1A) and 
then dissociated with NeuroCult
®
 chemical dissociation Kit (Stem Cell Technologies, 
Grenoble, France). Cells were adhered to SuperFrost Plus glass slides (Thermo 
Scientific, Menzel GmbH & Co KG, Braunscheweig, Germany) by centrifugation (360 
xg, 5 min; Cellspin I, Tharmac GmbH, Waldsoms, Germany), and fixed in 4% 
paraformaldehyde (PFA). Afterwards, terminal deoxynucleotidyl transferase dUTP 
nick-end labeling (TUNEL) assay was performed to label apoptotic nuclei, as 
previously described by us (Baptista et al., 2012). Briefly, cells were rinsed 3x 10 min 
with 0.01 M phosphate-buffered saline (PBS) and permeabilized in 0.25% Triton X-100 
for 30 min at room temperature. Cells were then incubated with terminal 
deoxynucleotidyl transferase buffer (0.25 U/µl terminal transferase, 6 µM biotinylated 
dUTP, pH 7.5; Roche, Basel, Switzerland) for 1 h at 37ºC in a humidified chamber. 
Afterwards, cells were rinsed with a termination buffer solution (300 mM NaCl and 30 
mM sodium citrate) for 15 min, followed by PBS for 5 min and incubated with 
Fluorescein (1:100; Vector Laboratories, Burlingame, USA) for 1 h. Additional SRY 
(sex determining region Y)-box 2 (Sox2) immunostaining was performed (as described 
in the immunocytochemistry section) to identify stem cells. Finally, nuclei were 
counterstained with 4 µg/ml Hoechst 33342 (Sigma-Aldrich) for 5 min and mounted in 
Dako fluorescence mounting medium (Dako, Glostrup, Denmark). Cells counts were 
obtained from 6 microscope fields of each coverslip, from 3 independent cultures 
performed in triplicate.  
 
2.3 Immunocytochemistry 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
8 
 
DG cell cultures or neurospheres were fixed in 4% PFA for 30 min, permeabilized in 
1% Triton X-100 and 3% bovine serum albumin (BSA; all from Sigma-Aldrich, St 
Louis, MO, USA) in PBS, followed by overnight incubation at 4ºC with the following 
antibodies: goat polyclonal anti-Sox2 (1:200; Santa Cruz Biotechnology, Heidelberg, 
Germany), goat anti-doublecortin (DCX, 1:500; Santa Cruz Biotechnology) and rabbit 
polyclonal anti-glial fibrillary acidic protein (GFAP, 1:500; Sigma-Aldrich). Then, cells 
were rinsed with PBS and incubated for 1 h with the appropriate secondary antibodies: 
donkey anti-goat Alexa Fluor 594 or donkey anti-rabbit Alexa Fluor 488 (both 1:200; 
Life Technologies). Afterwards, nuclei were stained with 4 µg/ml Hoechst 33342 
(Sigma-Aldrich) and slides were mounted in Dako. Fluorescence images for cells 
counts were recorded using a fluorescence microscopy (Leica DMIRE200, Wetzler, 
Germany). 
 
2.4 Cell cycle analysis 
Six-day-old DG primary neurospheres were exposed to 1 nM METH for 24 h or 72 h 
(Fig. 2A), dissociated and fixed in 70% ethanol for 20 min at 4ºC. Then, cells were 
centrifuged at 550 xg for 5 min and ressuspended in a solution containing 2% Fetal 
Bovine Serum (FBS; Life Technologies) in PBS. Afterwards, 10
6
 cells/ml were 
incubated with 10 μM Vybrant® Dye Cycle Orange (Life Technologies), which is a 
DNA-selective and membrane permeant probe that binds stoichiometrically to DNA 
and becomes fluorescent upon binding, in the presence of 0.1% Triton X-100 for 45 min 
at 37ºC. Afterwards, cells in suspension were centrifuged at 550 xg for 5 min and 
resuspended in 2% FBS in PBS. Approximately 30,000 events were analyzed on a 
FACS Calibur flow cytometer (Becton Dickinson, San Jose, CA, USA) and cell cycle 
was analyzed using the ModFit software.  
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Cell quiescence was assessed in DG neurospheres treated with 1 nM METH for 
24 h (Fig. 2A). Neurospheres were dissociated to single cells (NeuroCult
®
) and 
incubated for 15 min at 37ºC with 1 µg/ml Hoechst 33342 (Life Technolgies) and 1 
µg/ml pyronin-Y (Sigma-Aldrich), a fluorescent probe that binds to RNA, in culture 
medium supplemented with 0,1% Triton. Then, cells were centrifuged for 5 min at 550 
xg, resuspended in culture medium and analyzed on a FACS Aria III (Becton 
Dickinson). In detail, pyronin-Y was excited at 488 nm and red fluorescence was 
collected at 545/35 nm, and Hoechst 33342 was excited at 355 nm (UV) and blue 
fluorescence was recorded at 450/50 nm. A total of 10000 cells were analyzed per 
sample at a velocity of 400 events/second. Proper controls consisting of cells incubated 
with either Hoechst 33342 or Pyronin-Y were performed to calibrate the cytometer. 
Also, to exclude dead cells, DG cells were incubated with 2 µg/ml propidium iodide 
(Sigma-Aldrich). Data were analyzed using the flowJo software. 
 
2.5 Western blot analysis 
To evaluate cyclin A, D1 and E protein levels, 6-day-old neurospheres were exposed to 
1 nM METH or to 10 nM METH for cyclin E protein levels determination during 24 h 
(Fig. 3A). Moreover, phospho-epidermal growth factor receptor (pEGFR), epidermal 
growth factor receptor (EGFR), phospho-fibroblast growth factor receptor 1 (pFGFR1), 
phospho-extracellular-signal-regulated kinases 1/2 (pErk1/2) and extracellular-signal-
regulated kinases 1/2 (ERK1/2) protein levels were analyzed in DG neurospheres 
exposed to 1 or 10 nM METH for 6 or 24 h (Fig. 4A). Regarding DCX and GFAP 
protein levels, DG cells were exposed to 1 or 10 nM METH for 6 days (Fig. 7A) and the 
resulting neurospheres were harvested. Then, DG neurospheres were homogenized in 
RIPA buffer containing 150 mM NaCl, 5 mM EGTA, 50 mM Tris, 1% (v/v) Triton X-
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100, 0.1% SDS and 0.5% sodium deoxycholate, supplemented with a protease inhibitor 
cocktail tablet (Roche, Amadora, Portugal) in the ratio of 1 tablet/10 ml RIPA buffer. 
Afterwards, cells were centrifuged at 17000 xg for 15 min and protein concentration 
was determined using the bicinchoninic acid (BCA) Protein Assay (Thermo Fisher 
Scientific, Northumberland, UK). Then, 10 µg or 30 µg of protein samples were 
separated by electrophoresis in a 8% or 12% SDS-PAGE, respectively, transferred to a 
polyvinylidene dofluoride (PVDF) membrane (Millipore, Algés, Portugal) and blocked 
in a solution of 5% non-fat dried milk or 4% BSA in PBS-0.5% Tween (PBS-T; Sigma-
Aldrich) for 1 h. Membranes were probed overnight at 4ºC with mouse monoclonal 
anti-cyclin A (1:200; Abcam, Cambridge, UK), mouse monoclonal anti-cyclin D1 
(1:100), mouse monoclonal anti-cyclin E (1:100), rabbit polyclonal anti-p21 (1:200), 
mouse monoclonal anti-p27 (1:200) (all from Santa Cruz Biotechnology), mouse 
monoclonal anti-pEGFR (1:500; Millipore), rabbit polyclonal anti-EGFR (1:200; 
Abcam), rabbit monoclonal anti-pFGFR1 (1:200; Abcam), rabbit monoclonal anti-
pERK1/2 (Thr202/Tyr204; 1:200; Cell Signaling Technology, Beverly, MA, USA), 
rabbit monoclonal anti-ERK1/2 (1:200; Cell Signaling Technology), rabbit polyclonal 
anti-GFAP (1:1000; Sigma-Aldrich), goat polyclonal anti-DCX (1:200; Santa Cruz 
Biotechnology), mouse monoclonal anti-β-actin (1:10000; Sigma-Aldrich) and rabbit 
polyclonal anti-GAPDH (1:500; Sigma-Aldrich). Then, membranes were rinsed in PBS-
T and incubated for 45 min with alkaline phosphatase-conjugated secondary antibodies 
as follows: anti-rabbit IgG, (1:20000; GE Healthcare Europe GmbH, Freiburg, 
Germany), anti-mouse (1:10000, GE Healthcare Europe GmbH) and anti-goat IgG, 
(1:10000, Zymax, California, USA). Densitometric analysis was performed using the 
ECF reagent (GE Healthcare Europe GmbH), visualized on the Typhoon 9000 system 
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(GE Healthcare Europe GmbH), and band intensities were quantified using the 
ImageQuant 5.0 software. 
 
2.6 Neurosphere self-renewal assay 
Self-renewal capacity of DG stem/progenitor cells was assessed using the neurosphere 
assay. In detail, DG cells were seeded at clonal density of 10 cells/µl (Coles-Takabe et 
al., 2008; Pastrana et al., 2011) into uncoated 24-well plates and incubated with 1 or 10 
nM METH for 6 days and the total number of primary neurospheres in each well was 
determined (Fig. 5A). Afterwards, primary neurospheres were dissociated (NeuroCult
®
 
chemical dissociation kit, Stem Cell Technologies) and cells were reseeded as 
aforementioned without treatments for 6 additional days (Fig. 4A). The total number of 
resulting secondary neurospheres was determined in each well. Results are expressed as 
percentage of the control (untreated) in both primary and secondary neurospheres from 
at least 3 independent cultures and performed in triplicate (3 wells per condition within 
the 24-well plate). 
 
2.7 Cell-fate studies: cell pair assay 
Uncommitted stem cells can divide symmetrically into two stem cells (Sox2
+
/Sox2
+
) or 
into two progenitor cells (Sox2
-
/Sox2
-
), or asymmetrically into one uncommitted cell 
and one committed progenitor cell (Sox2
+
/Sox2
-
). Taking advantage of these properties, 
we analyzed if METH interferes with cell-fate division. For that, cell pair assay was 
performed as previously described (Bernardino et al., 2012; Santos et al., 2012; Xapelli 
et al., 2013) with some modifications. Hence, stem cells were directly isolated from 
mice DG and 10000 cells (8840 cells/cm
2
) were plated onto poly-D-lysine-coated 
(Sigma-Aldrich) glass coverslips. After seeding, cells were pre-incubated with 10 µM 
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(5R,10S)-(–)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cylcohepten-5,10-imine maleate 
(MK-801; Tocris) for 15 min and then co-exposed with 1 or 10 nM METH for 24 h 
(Fig. 6A). Then, immunocytochemistry to Sox2 was performed (section 2.3). A total of 
40 pairs of daughter cells that resulted from the division of one stem cell was 
characterized according to its symmetric cell division towards self-renewal 
(Sox2
+
/Sox2
+
) and differentiation (Sox2
-
/Sox2
-
), or asymmetric cell division 
(Sox2
+
/Sox2
-
). Results are expressed as percentage of control (untreated) from at least 2 
independent cultures performed in triplicate. 
 
2.8 Data analysis 
Statistical analysis was determined from at least two independent cultures and by using 
an analysis of variance (one-way ANOVA) followed by Dunn’s multiple comparison or 
Mann Whitney post-hoc tests, as indicated in the figure legends. Data are expressed as 
mean + standard error of the mean (SEM) from at least 2 independent cultures in which 
each condition was performed in duplicate or triplicate, and statistical significance level 
was set for P < 0.05. 
 
3 Results 
 
3.1 Methamphetamine can induce dentate gyrus stem cell death 
Several studies have previously shown that METH can be toxic to different brain cells 
(Deng et al., 2002; Genc et al., 2003; Mandyam et al., 2007), but the direct effect of this 
drug on DG stem cells has never been addressed before. Thus, in the present study we 
started by evaluating the toxic effect of METH on DG stem cells by quantifying the 
number of positive cells for TUNEL and Sox2 (Figs. 1B and 1C). We observed that 10 
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nM METH did not induce cell death to Sox2-positive cells (111.00 + 24.51% of control; 
Fig. 1C). However, 100 nM METH was toxic to DG neurospheres observed by the 
significant increase of Sox2- and TUNEL-positive cells (196.20 + 26.26% of control; P 
< 0.01; Fig. 1C).  
 
3.2 Methamphetamine delays dentate gyrus cell cycle 
Based on our previous results (Fig. 1C) and in order to select drug concentrations more 
similar to those frequently present in the brain of METH users, we decided to use 1 
or/and 10 nM of METH in the following studies. Noteworthy, both concentrations did 
not induce stem cell death. Thus, we analyzed the effect of METH (1 nM) on cell cycle 
progression and, after 24 h, there was an increase in the population of cells in the G0/G1 
phase (61.59 + 2.77%, P < 0.01) when compared to the control (48.91 + 2.12%; Fig. 
2B). Furthermore, METH induced a decrease in the percentage of cells in the S phase 
(control: 36.86 + 2.81%; METH: 27.72 + 1.69%, P < 0.01; Fig. 2B). Regarding the 
G2/M phases, no differences were observed between METH and control conditions 
(control: 15.04 + 0.77%; METH: 13.42 + 1.08%; Fig. 2B). To further clarify if METH 
induces cell cycle inhibition or delay, neurospheres were exposed to 1 nM METH for 72 
h (Fig. 2A). We concluded that METH no longer interfered with G0/G1 (control: 86.82 
+ 0.57%; METH: 85.41 + 0.92%), S (control: 9.37 + 0.16%; METH: 10.94 + 0.83%) or 
G2/M phases (control: 3.81 + 0.72%; METH: 3.64 + 0.42%; Fig. 2C), indicating that 
METH delays cell cycle progression rather than inhibiting it.  
 To disclose whether delay in the cell cycle is due to entry in quiescence (G0), 
DG neurospheres were exposed to 1 nM METH for 24 h (Fig. 2A) and then incubated 
with Hoechst 33342 and pyronin Y to label DNA and mRNA, respectively. Quiescent 
cells possess less mRNA than actively cycling cells and therefore display low levels of 
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pyronin Y-emitted fluorescence. As represented in Fig. 2D, METH increased in about 
20% the cell population that rests in G0 (control: 16.5%; METH: 36.4%).  
After demonstrating that METH impairs the progression of DG stem cells from 
G0/G1 to S phase of the cell cycle, we further investigated possible alterations of 
cyclins D1, E and A, since these proteins are involved in the cell cycle progression. It 
was possible to conclude that METH (1 nM) did not induce alterations of cyclin D1 
(control: 100.00 + 17.06%; METH: 94.40 + 10.10% of control; Fig. 3B) or cyclin A 
protein levels (control: 100.00 + 12.04%; METH: 104.60 + 13.93% of control; Fig. 3E). 
On the other hand, the expression of cyclin E was down-regulated by this drug (control: 
100.00 + 4.36%; METH: 90.20 + 1.52% of control; P < 0.05; Fig. 3C). A similar down-
regulation of cyclin E was observed with 10 nM METH (control: 100.00 + 12.74%; 10 
nM METH: 49.46 + 8.18% of control; P < 0.05; Fig. 3D). Afterwards, we assessed the 
protein levels of both p21 and p27, the main inhibitors of the complexes cyclin 
D1/Cdk4/6 and cyclin E/Cdk2, respectively. Thus, METH neither altered the protein 
levels of p21 (control: 100.00 + 13.38%; METH: 102.60 + 7.34% of control; Fig. 3F) 
nor of p27 (control: 100.00 + 11.64%; METH: 101.40 + 5.93% of control; Fig. 3G). 
Additionally, since activation of ERK1/2 is highly involved in cell proliferation 
through the upstream activation of EGFR (Gampe et al., 2011) or FGFR1 (Xiao et al., 
2007), we determined the effect of METH on the phosphorylation levels of FGFR1, 
EGFR and ERK1/2. Indeed, METH (1 nM) did not change the protein levels of 
pFGFR1 (control: 100.00 + 9.44%; METH: 86.02 + 12.00% of control; Fig. 4B) at 6 h 
of drug exposure, whereas decreased protein levels of pEGFR (control: 100.00 + 9.77%; 
METH: 48.60 + 13.37% of control; P < 0.05; Fig. 4C) and pERK1/2 (control: 100.00 + 
3.95%; METH: 82.02 + 2.11% of control, P < 0.05; Fig. 4D) in DG neurospheres at 6 h 
post-METH exposure. However, after 24 h of METH (1 nM) treatment, pERK1/2 
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protein levels were similar to control (101.60 + 5.52% of control; Fig. 4D). The same 
effect was observed with 10 nM METH (control: 100.00 + 2.68%; METH 6 h: 77.68 + 
5.66% of control, P < 0.05; METH 24 h: 123.70 + 13.78% of control; Fig. 4E).  
 
3.3 Methamphetamine decreases dentate gyrus neurosphere self-renewal 
DG stem cells have the ability to self-renew and this capacity was assessed using the 
neurosphere assay (Coles-Takabe et al., 2008; Pastrana et al., 2011). Thus, METH (1 
nM) decreased the number of primary neurospheres (control: 100.00 + 5.29%; METH: 
76.77 + 5.29% of control, P < 0.01; Fig. 5B). However, no differences in the number of 
secondary neurospheres were observed (control: 100.00 + 6.05%; METH: 96.79 + 
8.56% of control; Fig. 5B) indicating that 1 nM METH did not interfere with self-
renewal capacity of DG stem/progenitor cells. In parallel, a higher concentration of 
METH (10 nM) also decreased the number of primary neurospheres (72.37 + 2.06% of 
control, P < 0.05; Fig. 5C). Interestingly, the number of secondary neurospheres was 
also decreased (control: 100.00 + 4.97%; METH: 76.47 + 3.57% of control, P < 0.01; 
Fig. 5C) showing that METH at 10 nM decreases self-renewal capacity.   
 
3.4 Methamphetamine shifts cell fate towards differentiation via activation of 
NMDA receptors 
DG stem cells can self-renew, i.e., one stem cell can divide and give rise at least to one 
identical cell to itself and/or generate progenitors that undergo differentiation (Gage, 
2000). Herein, we observed that 1 nM METH had no effect on DG symmetric cell 
division towards self-renewal (Sox2
+
/Sox2
+
: 87.01 + 6.60% of control; Fig. 6B). 
Similarly, no effect was verified on symmetric cell division towards differentiation 
(Sox2
-
/Sox2
-
: 110.90 + 4.63% of control) or on asymmetric cell division (Sox2
+
/Sox2
-
: 
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99.07 + 7.00% of control; Fig. 6B). However, 10 nM METH decreased the number of 
Sox2
+
/Sox2
+
 pairs of cells (53.74 + 4.69% of control; P < 0.01), and the blockade of 
NMDA receptors with MK-801, completely prevented the effect induced by METH 
(99.34 + 10.52% of control, P < 0.05 compared to METH alone; Fig. 6C). Furthermore, 
METH induced an increase of Sox2
-
/Sox2
-
 pairs of cells and MK-801 also prevented 
this effect (METH: 191.10 + 8.20%, P < 0.01; METH + MK-801: 78.57 + 9.82% of 
control, P < 0.001 compared to METH alone; Fig. 6C). On the other hand, 10 nM 
METH did not affect asymmetric cell division (Sox2
+
/Sox2
-
; Fig. 6C).  
 
3.5 Methamphetamine increases doublecortin expression in DG neurospheres 
As METH directs cell division towards differentiation, we further evaluated neuronal 
and astroglial differentiation in DG cells treated for 6 days with METH (Fig. 7A). 
Protein levels of DCX and GFAP, a marker for immature neurons and astrocytes, 
respectively, were determined by western blot. We observed that 1 nM METH did not 
interfere with both DCX (105.60 + 7.69% of control; Fig. 7B) and GFAP (94.14 + 
14.08% of control; Fig. 7C) protein levels. However, at a higher concentration (10 nM) 
METH was able to up-regulate DCX expression (133.70 + 6.83% of control; P < 0.05; 
Fig. 7B and D), whereas no changes were observed in GFAP protein levels (93.05 ± 
4.29% of control, Fig. 7C and D). Overall, these results demonstrate that 10 nM METH 
directs DG stem/progenitor cell differentiation towards the neuronal fate.  
 
4 Discussion 
The present work addresses the effect of the drug of abuse METH on DG stem cell 
properties. Indeed, our results show that METH at nontoxic concentrations impaired 
stem cell properties, specifically by decreasing self-renewal capacity, delaying cell 
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cycle progression and directing cell fate division towards differentiation. Firstly, we 
verified that METH (100 nM) induced cell death of Sox2
+
 DG stem/progenitor cells 
from free floating neurospheres, having no effect at a lower concentration (10 nM). 
Interestingly, we have previously shown that exposure to 10 nM METH for 24 h 
induced cell death on plated DG-derived neurosphere cultures (Baptista et al., 2012). 
Thus, we may conclude that neurospheres plated on poly-D-lysine and in a medium 
devoid of growth factors initiate differentiation and are more sensitive to METH 
toxicity as compared to free floating Sox2
+
 neurospheres cultured in the presence of 
growth factors. This difference may rely on differential abilities to repair DNA damages 
(Fernando et al., 2011), to counteract oxidative stress (Le Belle et al., 2011) or/and 
METH-induced apoptosis mechanisms displayed by stem/progenitor cells versus 
committed progenitors.  
Herein, we also explored for the first time the impact of METH on the cell cycle 
of DG stem cells. It was possible to observe a delay in the transition from G0/G1 to the 
S phase, an increase of cell population in the quiescence state (phase G0), and a down-
regulation of cyclin E protein, which forms a complex with cyclin-dependent kinase 2 
(Cdk2) being involved in the progression through the G1 phase and initiation of DNA 
replication in the S phase (Mazumder et al., 2004). Accordingly, to confirm that METH 
delays cell cycle progression, the doubling time for cell division was assessed and we 
observed that DG cells undergo two cell divisions in 24 h (data not shown). On the 
other hand, METH did not induce any alterations in both cyclin D1 and cyclin A protein 
levels, which lead us to conclude that METH specifically impairs G1-to-S transition. In 
fact, little information is available regarding the effect of METH in cell cycle. 
Nevertheless, Yuan and collaborators (2011) assumed that hippocampal proliferating 
cells may be arrested in the G1 phase by METH (self-administration of 0.05 
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mg/kg/injection, 6 h/daily for 13 days) since they observed not only a decreased number 
of cells in the S phase, but also of cells that enter and exit the S phase without changing, 
however, its length. In fact, other psychostimulants like cocaine (10 or 100 µM, 
nontoxic concentrations) also interfere with the transition from G1-to-S phase in AF5 
progenitor cells (a rat mesencephalic cell line), confirmed by the down-regulation of 
cyclin A2 (Lee et al., 2008). The authors further demonstrated that this effect was 
triggered by oxidative endoplasmic reticulum stress (Lee et al., 2008). Additionally, Hu 
and colleagues (2006) observed that cocaine inhibited proliferation in human fetal 
neural progenitor cells with simultaneous increase of the cyclin-dependent kinase 
inhibitor, p21. Moreover, very recently Blanco-Calvo and collaborators (2014) showed 
that acute administration of cocaine (10 mg/kg) decreases the number of proliferating 
cells in the subgranular zone, which was prevented by the inhibition of cannabinoid 
CB1 or CB2 receptors. Cannabinoid receptor blockade was also able to prevent 
hippocampal-dependent contextual memories induced by cocaine (Blanco-Calvo et al., 
2014).  
On the other hand, with the present study we verified that METH did not alter 
protein expression of cyclin inhibitors, p21 and p27, which suggests the involvement of 
other mechanisms in METH-induced cyclin E down-regulation. In fact, Heo and 
collaborators (2006) showed that blockade of MAPK pathway with PD-98059 (MEK1 
inhibitor) decreased both cyclins D1 and E protein levels. These authors investigated the 
involvement of MAPK pathway activation in cell proliferation by stimulating mouse 
embryonic stem cells with epidermal growth factor (EGF), which induced an increase in 
the phosphorylate state of ERK1/2 and cyclin E proteins (Heo et al., 2006). 
Furthermore, homocysteine, a sulfur-containing intermediate of methionine metabolism, 
decreased phosphorylation of ERK1/2 and cyclin E protein expression in mice SVZ 
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cells incubated with FGF-2 (Rabaneda et al., 2008). Based on our results, we may 
suggest that METH acts upstream to ERK1/2 by decreasing the phosphorylation levels 
of EGFR, which will interfere with the MAPK pathway through down-regulation of 
pERK1/2 followed by a decrease in cyclin E expression, that in turn will affect cell 
cycle progression and resulting in the impairment of DG stem cell self-renewal. In fact, 
little is known regarding the effect of METH on EGFR, but it was previously 
demonstrated that neonatal EGF administration increased METH-induced locomotor 
responses (Mizuno et al., 2004). Still, it was shown that EGFR plays an active role in 
promoting cell proliferation and neuronal differentiation in the SGZ, as well as in 
rescuing neurogenesis in aged rats (Jin et al., 2003). Additionally, in a Parkinson’s 
disease animal model, EGFR expression is down-regulated in proliferating cells in the 
SVZ (Hӧ glinger et al., 2004). Furthermore, it was demonstrated that EGFR expression 
and signaling was reduced in the SVZ of aged mice, which resulted in a decrease of cell 
proliferation and neurogenesis (Enwere et al., 2004). Consistent with this finding, we 
suggest that METH decreases the expression of pEGFR, which down-regulates MAPK 
signaling as verified by a transient decrease of ERK1/2 phosphorylation, which could 
lead to down-regulation of cyclin E and, consequently, a decrease in DG stem cell 
proliferation and self-renewal.  
Although MAPK pathway can mediate cell proliferation, it can also be involved 
in memory performance. Indeed, depending on the frequency of METH exposure, an 
acute (Cao et al., 2013) or chronic (Ito et al., 2007) administration can improve or 
decline memory performance, accompanied with an increase or decrease in the 
phosphorylation levels of ERK1/2, respectively. Furthermore, ERK1/2 activation leads 
to the activation of the downstream transcription factor cyclic adenosine 
monophosphate response element-binding protein (CREB) followed by increased 
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expression of c-fos, which in the DG identifies neurons processing spatial information 
(Sweatt, 2001). Noteworthy, activation of ERK1/2 is necessary to generate long-term 
potentiation in DG immature neurons (Darcy et al., 2014). Interestingly, Kee and 
collaborators (2007) verified that immature neurons present increased c-fos expression, 
which strongly suggest that these cells are recruited to integrate spatial memory 
circuitries. Accordingly, in the present study we demonstrate that METH transiently 
decreased pERK1/2 protein levels in DG stem cells and increased immature neurons, 
which allow us to hypothesize that these neurons can be synaptically active and though 
participate in memory processes.   
Other important characteristic of neural stem cells is the ability to self-renew. 
Thus, we further explored for the first time the effect of METH on DG stem cell self-
renewal. METH, at nontoxic concentrations (1 nM or 10 nM), was able to decrease the 
number of primary neurospheres, showing that this drug has a negative effect on stem 
cell proliferation. In fact, the findings obtained in cell cycle analysis can be correlated 
with the decreased number of primary neurospheres. Specifically, METH delayed 
G0/G1-toS phase progression which decreased the proliferative capacity of DG stem 
cells and, consequently, could decrease the number of neurospheres. Also, at the highest 
nontoxic concentration (10 nM), METH decreased the number of secondary 
neurospheres proving that it affects DG stem cell self-renewal. Some studies addressed 
the effect of METH on DG neurogenesis and focused mainly on cell proliferation. In 
detail, it has been described that METH (25 mg/kg) transiently decreases the number of 
BrdU-positive cells in gerbil dentate gyrus (Teuchert-Noodt et al., 2000). Moreover, 
Mandyam and collaborators (2008) observed that this drug (0.05 mg/kg/infusion) 
administered 1 h/day and 6 h/day decreases the number of proliferating cells, 
characterized by the decreased number of Ki-67-positive cells, a protein expressed 
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during the active phases of the cell cycle. Also, METH induces long-term effects in 
SGZ stem/progenitor cell proliferation, as described by Schaefers and colleagues (2009) 
showing that a single METH administration (50 mg/kg) to 14-day-old gerbils decreases 
the number of BrdU-positive cells, 45 days post-administration. In addition, our group 
demonstrated that 100 µM METH (48 h of exposure) reduced proliferation in SVZ 
cultures (Bento et al., 2011).  
As METH impairs self-renewal capacity, we also explored the influence of 
METH in DG stem cell-fate division, a suitable method to characterize the phenotype of 
cells that are derived from the division of one DG stem cell. Indeed, a stem cell can 
undergo symmetric cell division towards self-renewal, where the two resulting cells are 
both stem cells (Sox2
+
/Sox2
+
 pairs of daughter cells), and towards differentiation, 
resulting two cells that are committed to differentiate (Sox2
-
/Sox2
-
 pairs of daughter 
cells). Moreover, one stem cell can divide asymmetrically, originating one pair of cells 
consisting in one Sox2
+
 and one Sox2
-
 cell.  Accordingly, we found  that METH (10 
nM) decreased self-renewal symmetric cell division (Sox2
+
/Sox2
+
 pairs of daughter 
cells), directing division towards Sox2
-
/Sox2
-
 pairs of daughter cells consistent with cell 
commitment. In fact, an animal study showed that Sox2-positive cells in the SGZ are 
able to undergo symmetric or asymmetric cell division, in which one Sox2-positive cell 
can give rise to one neuron and one astrocyte, or to one neural stem cell and one neuron, 
respectively (Suh et al., 2007). Also, we observed that these alterations could be, in part, 
due to the activation of NMDA receptor signaling because inhibition of these receptors 
prevented the shift of cell division towards differentiation. Moreover, we had previously 
demonstrated that METH induces an increase of glutamate release from DG 
neurospheres and the inhibition of NMDA receptors protects DG cells from METH 
toxicity (Baptista et al., 2012). In fact, several brain injuries, such as status epilepticus 
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(Sugaya et al., 2010), cerebral ischemia (Choi et al., 2012) and traumatic brain injury 
(Zheng et al., 2013) can increase neurogenesis, and glutamate seems to play a central 
role upon activation of NMDA receptors (Arvidsson et al., 2001; Urbach et al., 2008). 
Indeed, Nacher and colleagues (2003) observed that a single injection of NMDA 
receptor antagonist (CGP-43487, 5 mg/kg) prevents age-induced decrease of SGZ cell 
proliferation and neurogenesis in both middle-aged (10 month-old) and aged (20 month-
old) Fisher F344 rats. Moreover, administration of NMDA (30 mg/kg) to Sprague-
Dawley rats decreased the population of proliferating cells in the DG, whereas 
administration of MK-801 or CGP37849 resulted in the opposite effect (Cameron et al., 
1995). Also, MK-801 administration (3 mg/kg) to NMDA-infused (2 mg/ml) Wistar rats 
increases the phosphorylated levels of ERK in newly generated neurons (Okuyama et 
al., 2004), which strengths the involvement of NMDA receptors in decreasing cell 
proliferation through regulation of the MAPK pathway. Moreover, Deisseroth and 
collaborators (2004) demonstrated that NMDA receptors play an active role in neuronal 
differentiation, showing that excitatory stimuli induced by NMDA receptor activation 
enhances expression of NeuroD, a downstream regulator of neuronal differentiation, and 
consequently increases neurogenesis in neural progenitor cells culture.  
The present study also reveals that METH (10 nM) enhanced differentiation into 
immature neurons in DG neurospheres, verified by the increase of DCX protein levels. 
This effect correlates with the fact that METH increases the pairs of cells that did not 
express Sox2 (Sox2
-
/Sox2
-
 cell pairs), i.e., differentiating cells. Furthermore, cell cycle 
alterations induced by METH suggest a differentiation shift. In fact, the length of G1 
phase may influence the decision for a neural stem cell to proliferate or differentiate as 
reviewed by Salomoni and Calegari (2010). Furthermore, METH did not induce any 
alterations in GFAP expression, indicating that immature neurons are preferentially 
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generated rather than astrocytes. In accordance to our findings, it was described by 
Mandyam and collaborators (2008) that METH self-administration (0.05 
mg/kg/infusion, 1 h/day, 2 days/week for 49 days) increases neuronal differentiation 
and maturation of hippocampal progenitor cells.  
 
5 Conclusions 
 Our results show that METH interferes with DG stem cell proliferation, an effect 
due to a delay on cell cycle G0/G1-to-S transition involving down-regulation of 
pEGFR, cyclin E and and pERK1/2. Additionally, METH impairs DG cell self-renewal 
capacity via NMDA signaling. These effects could be useful to elucidate the impairment 
of hippocampal neurogenesis and memory deficits in METH abusers. 
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Figure legends 
 
Figure 1  METH can induce DG stem/progenitor cell death. (A) Schematic 
representation of the experimental design to assess DG cell death. DG neurospheres 
were exposed to METH (10 or 100 nM) for 24 h and the number of TUNEL- and Sox2-
positive cells was determined to evaluate apoptotic cell death of stem cells. (B) 
Representative fluorescence images of a TUNEL-positive nucleus (green) of a Sox2-
positive stem cell (red) from a control condition. Scale bar: 10 µm. (C) Quantification 
of TUNEL- and Sox2-positive cells in the presence of 10 or 100 nM METH. Only the 
highest concentration was toxic to stem cells. Data are expressed as % of control + SEM 
from at least 2 independent cultures where each condition was performed in duplicate. 
**P < 0.01, significantly different from control, using Kruskal-Wallis test followed by 
Dunn’s multiple comparison post-hoc test. 
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Figure 2  METH delays DG neurosphere cell cycle in the transition from G0/G1 to 
S phase and induces stem/progenitor cell quiescence. (A) Schematic representation of 
the experimental protocol for cytometry analysis. (B, C) Quantification of cells present 
in different phases of the cell cycle after (B) 24 h or (C) 72 h of METH exposure. (B) 
METH increases the population of cells in the G0/G1 phase while decreasing the S 
phase. (C) In contrast, METH does not induce any alterations in cell cycle at 72 h 
exposure. Data are expressed as % of cells + SEM from at least 2 independent cultures 
and each condition was performed in duplicate. **P < 0.01, significantly different from 
control using Mann Whitney post-hoc test. (D) METH (1 nM for 24 h) increases the 
number of cells in quiescent phase (G0) as showed by the representative dot plots 
(representative experiment of 3 independent cultures). 
 
Figure 3  METH down-regulates cyclin E protein levels in DG neurospheres. (A) 
Schematic representation of the experimental design for western blot studies. METH (1 
nM) does not induce alterations in (B) cyclin D1 (37 kDa) or (E) cyclin A (60 kDa) 
protein expression, but (C) down-regulates cyclin E (53 kDa) expression, which is also 
observed at (D) 10 nM METH. Additionally, METH (1 nM) does not interfere with (F) 
p21 (21 kDa) and (G) p27 (27 kDa) expression, the main inhibitors of the complexes 
cyclin D1/Cdk4/6 and cyclin E/Cdk2, respectively.  Above the bars, representative 
western blot images of the different proteins are shown, including the housekeeping 
gene β-actin (42 kDa) or GAPDH (36 kDa). Data are expressed as % of control + SEM 
from at least 4 independent cultures.  *P < 0.05, significantly different from control 
using Mann Whitney post-hoc test. 
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Figure 4 METH down-regulates the phosphorylation form of EGFR and ERK1/2. 
(A) Schematic representation of the experimental design for western blot studies. 
Exposure to METH (1 nM) for 6 h does not induce any effect in (B) pFGFR1 (130 
kDa), but (C) down-regulates the phosphorylation levels of EGFR (175 kDa). In 
addition, (D) 1 nM or (E) 10 nM METH decreases the phosphorylation form of ERK1/2 
(42/44 kDa) after 6 h of drug exposure, but no alterations were observed after 24 h. Data 
are expressed as % of control + SEM from at least 4 independent cultures. *P < 0.05, 
significantly different from control using Mann Whitney or Kruskal-Wallis test 
followed by Dunn’s Multiple comparison post-hoc tests. §§P < 0.01, significantly 
different from METH 6 h-exposure using Kruskal-Wallis test followed by Dunn’s 
Multiple comparison post-hoc test. 
 
Figure 5  METH decreases DG neurosphere self-renewal. (A) Schematic 
representation of the experimental design to evaluate the impact of METH on self-
renewal capacity of DG stem/progenitor cells. (B) METH (1 nM) decreases the number 
of primary neurospheres, but does not induce any effect on the number of secondary 
neurospheres. (C) However, 10 nM METH is able to decrease both the number of 
primary and secondary neurospheres. Data are expressed as % of control + SEM from 3 
independent cultures and each condition was performed in triplicate. *P < 0.05; **P 
<0.01, significantly different from control using Mann-Whitney post-hoc test. 
 
Figure 6  METH triggers DG cell-fate division towards differentiation via 
activation of NMDA receptors. (A) Schematic representation of the experimental design 
to evaluate how METH interferes with cell fate. (B) METH (1 nM) does not induce any 
alterations in DG cell-fate division. (C) Nevertheless, a higher concentration of the drug 
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(10 nM METH) decreases the number of Sox2
+
/Sox2
+
 pairs of daughter cells, which 
was completely prevented by the NMDA receptor inhibitor, MK-801 (10 μM), and 
increases the number of Sox2
-
/Sox2
-
 pairs of cells without altering asymmetric cell 
division (Sox2
+
/Sox2
-
). Data are expressed as % of control + SEM from at least 2 
independent cultures where each condition was performed in triplicate. **P < 0.01, 
significantly different from control using Kruskal-Wallis test followed by Dunn´s 
Multiple comparison test. 
§
P < 0.05; 
§§§
P < 0.001, significantly different from 10 nM 
METH using Kruskal-Wallis test followed by Dunn´s Multiple comparison test. (D) 
Representative fluorescence images showing Sox2
+
/Sox2
+
 (symmetric self-renewing 
cell division), Sox2
+
/Sox2
-
 (asymmetric cell division), and Sox2
-
/Sox2
-
 (symmetric 
differentiation division) pairs of cells. Scale bar: 5 µm. 
 
Figure 7  METH increases immature neurons in DG neurospheres. (A) Schematic 
representation of the experimental design of DG cells to evaluate the effect of METH on 
DG neurospheres growth. (B) METH (10 nM) increases DCX (40 kDa) protein levels, 
but without an effect on (C) GFAP (50 kDa) expression. Data are expressed as % of 
control + SEM from at least 2 independent cultures. *P < 0.05, significantly different 
from control using Kruskal-Wallis test followed by Dunn´s Multiple comparison test. 
(D) Representative fluorescence images of DG neurospheres showing increased DCX 
(red) immunoreactivity in DG cells exposed to 10 nM METH, without inducing 
significant alterations in GFAP (green) expression. Nuclei were stained with Hoechst 
33342 (blue). Scale bar: 50 µm. 
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Graphical abstract  Schematic representation of the effect of methamphetamine in 
dentate gyrus stem cell properties. METH down-regulates the phosphorylation levels of 
EGFR and ERK1/2, compromising DG cell proliferation as observed by down-
regulation of cyclin E levels. As a result, METH increases the population of quiescent 
cells and delays the transition from G0/G1 to S phase of the cell cycle. These effects 
may result in the decrease of DG stem cell self-renewal under METH exposure. The 
impairment of self-renewal can direct DG stem cells to differentiate as observed by the 
increase of DCX expression in neurospheres. 
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Highlights 
 
METH decreases the phosphorylation levels of EGFR and ERK1/2 
 
METH delays cell cycle in G0/G1-to-S phase transition and decreases cyclin E levels 
 
Methamphetamine (METH) decreases DG stem cells self-renewal 
 
METH shifts cell division towards differentiation via activation of NMDA receptors 
 
METH enhances neuronal differentiation in DG neurospheres 
